| Neutrophil Extracellular Traps in Breast Cancer: Roles in Metastasis and Beyond X Xu, X Wang, Z Zheng, Y Guo, G He, Y Wang, S Fu, C Zheng, X Deng Journal of Cancer 15 (11), 3272, 2024 | | 2024 |
| Dysregulated Ribosome Biogenesis Is a Targetable Vulnerability in Triple-Negative Breast Cancer: MRPS27 as a Key Mediator of the Stemness-inhibitory Effect of Lovastatin C Zheng, H Yao, L Lu, H Li, L Zhou, X He, X Xu, H Xia, S Ding, Y Yang, ... International Journal of Biological Sciences 20 (6), 2130, 2024 | | 2024 |
| Disulfidptosis: Six Riddles Necessitating Solutions X Wang, C Zheng, H Yao, Y Guo, Y Wang, G He, S Fu, X Deng International Journal of Biological Sciences 20 (3), 1042, 2024 | 1 | 2024 |
| Amino acids and their roles in tumor immunotherapy of breast cancer H Xia, J Zhu, Z Zheng, P Xiao, X Yu, M Wu, L Xue, X Xu, X Wang, Y Guo, ... The Journal of Gene Medicine 26 (1), e3647, 2024 | | 2024 |
| Molecular Characterization and Establishment of a Prognostic Model Based on Primary Immunodeficiency Features in Association with RNA Modifications in Triple-Negative Breast Cancer H Xia, X Xu, Y Guo, X Deng, Y Wang, S Fu Genes 14 (12), 2172, 2023 | | 2023 |
| Neutrophils in triple-negative breast cancer: an underestimated player with increasingly recognized importance C Zheng, X Xu, M Wu, L Xue, J Zhu, H Xia, S Ding, S Fu, X Wang, Y Wang, ... Breast Cancer Research 25 (1), 88, 2023 | 12 | 2023 |
| A bibliometric analysis of 16,826 triple-negative breast cancer publications using multiple machine learning algorithms: Progress in the past 17 years K Wang, C Zheng, L Xue, D Deng, L Zeng, M Li, X Deng Frontiers in Medicine 10, 999312, 2023 | 1 | 2023 |
| The most likely but largely ignored triggering factor for breast (or all) cancer invasion Y Man, C Mannion, A Stojadinovic, GE Peoples, WCS Cho, SW Fu, X Tan, ... Journal of Cancer 14 (4), 573, 2023 | 3 | 2023 |
| A novel prognostic model for cutaneous melanoma based on an immune-related gene signature and clinical variables Y Tang, H Feng, L Zhang, C Qu, J Li, X Deng, S Zhong, J Yang, X Deng, ... Scientific Reports 12 (1), 20374, 2022 | 5 | 2022 |
| Triple-negative breast cancer: Heterogeneity, tumor microenvironment and targeted therapy X Deng, C Zheng, F Tang, TJ Rosol, ZM Shao Frontiers in Oncology 12, 1026566, 2022 | 6 | 2022 |
| Co-Expression and Combined Prognostic Value of CSPG4 and PDL1 in TP53-Aberrant Triple-Negative Breast Cancer ZY Hu, C Zheng, J Yang, S Ding, C Tian, N Xie, L Xue, M Wu, S Fu, Z Rao, ... Frontiers in Oncology 12, 804466, 2022 | 9 | 2022 |
| Nucleolar and coiled-body phosphoprotein 1 is associated with stemness and represents a potential therapeutic target in triple-negative breast cancer S Chen, Y Li, M Wu, L Xue, J Zhu, M Wu, Q Zhang, G He, G Li, S Fu, ... Frontiers in oncology 12, 731528, 2022 | 6 | 2022 |
| Lovastatin enhances chemosensitivity of paclitaxel-resistant prostate cancer cells through inhibition of CYP2C8 Y Li, S Chen, J Zhu, C Zheng, M Wu, L Xue, G He, S Fu, X Deng Biochemical and Biophysical Research Communications 589, 85-91, 2022 | 16 | 2022 |
| Hexokinase 2 is a pivot for lovastatin-induced glycolysis-to-autophagy reprogramming in triple-negative breast cancer cells L Xue, M Wu, Y Li, S Chen, M Wu, J Zhu, S Ding, Q Zhang, C Zheng, G He, ... Journal of Cancer 13 (12), 3368, 2022 | 4 | 2022 |
| Natural products inducing nucleolar stress: implications in cancer therapy M Wu, L Lu, S Chen, Y Li, Q Zhang, S Fu, X Deng Anti-Cancer Drugs 33 (1), e21-e27, 2022 | 2 | 2022 |
| Targeted therapeutic strategies for triple-negative breast cancer Y Li, Z Zhan, X Yin, S Fu, X Deng Frontiers in oncology 11, 731535, 2021 | 78 | 2021 |
| Quantitative and visualized analysis of 5,097 triple-negative breast cancer (TNBC) publications by using multiple machine learning algorithms: TNBC is an excellent forerunner … K Wang, C Zheng, L Xue, D Deng, F Tan, Q Pei, Y Li, D Wang, L Zeng, ... | | 2021 |
| Lovastatin inhibits EMT and metastasis of triple-negative breast cancer stem cells through dysregulation of cytoskeleton-associated proteins C Zheng, S Yan, L Lu, H Yao, G He, S Chen, Y Li, X Peng, Z Cheng, M Wu, ... Frontiers in Oncology 11, 656687, 2021 | 23 | 2021 |
| Immune checkpoint inhibition for triple-negative breast cancer: current landscape and future perspectives H Yi, Y Li, Y Tan, S Fu, F Tang, X Deng Frontiers in oncology 11, 648139, 2021 | 29 | 2021 |
| Biomaterials Science L Xiong, Q Li, X Deng Biomaterials 9 (6), 2021 | | 2021 |
